Anogenital Wart Burden and Cost of Illnesses
The study will be a prospective study of patients presenting with anogenital warts. The objective are to assess proportion of anogenital warts to the total number of sexual transmitted infection patients, to quantify direct and indirect cost of illnesses and psychological burden associated with anogenital warts and to estimate government program expenditure for the prevention and control and treatment of the STI/anogenital HPV infection.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Measurement of Anogenital Wart Burden, and Cost of Illnesses in Bangkok|
|Study Start Date:||June 2008|
|Study Completion Date:||August 2009|
|Primary Completion Date:||August 2009 (Final data collection date for primary outcome measure)|
An observational study, multiple visit, 2-center study will be conducted in Rajavithi General Hospital, and Bangrak Hospital. One hundred and fifty subjects will be enrolled from both hospitals. Anogenital wart patients presented in Rajavithi General Hospital and the STI clinic at Bangrak Hospital will be recruited prospectively. All patients will be treated according to standard medical guidelines or usual care of the institutes. After the baseline assessment, the patients will have follow up visits with their physicians and will also be interviewed at the clinical sites three time approximately at day 7 (-2+7 days), month 1 (+-7 days), and month 6 (+-7 days) until they are cure. At month 6 (+-14 days), telephone assessment for the capture of any signs of disease recurrence will be done. All patients will be followed for 6 months under the same schedule.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00749294
|Clinical Infectious Diseases Research Unit|
|Bangkok, Thailand, 10400|
|Principal Investigator:||Prof. Punnee Pitisuttithum, M.B.,B.S.||Mahidol University|